Today, prostate cancer (PCa) ranks second among other cancers and is a significant health concern for men [1, 2]. One in every six men will be diagnosed with prostate cancer during their lifetime, making it important for researchers and medical professionals to continue to study and improve treatment...
Imaging plays an increasingly important role in prostate cancer (PCa) diagnostics. Prostate magnetic resonance imaging (MRI) prior to prostate biopsy is currently the standard of care for patients with a clinical suspicion for PCa [1]. While MRI has greatly improved the diagnostic pathway for PCa, it...
Lung cancer continues to be the most prevalent malignant neoplasm worldwide [1], with its incidence rising annually [2]. In recent years, immunotherapy has emerged as a promising treatment for patients with non-small cell lung cancer (NSCLC), particularly in chemotherapy-resistant cases [3]. Gene signatures...
Dynamic [F]-sodium fluoride ([F]NaF) PET scans are not presently suitable for clinical practice. However, the measurement of standardized bone uptake would be an easier way of implementing the method. [F]NaF is a sensitive bone-seeking tracer and enables, in an unique way, the measurement of bone turnover...